• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed by Spindletop Health Acquisition Corp.

    2/17/22 3:32:09 PM ET
    $SHCA
    Consumer Electronics/Appliances
    Industrials
    Get the next $SHCA alert in real time by email
    SC 13G 1 p50757930a.htm SCHEDULE 13G
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    SCHEDULE 13G

    Under the Securities Exchange Act of 1934
    (Amendment No.  )*

    Spindletop Health Acquisition Corp
    (Name of Issuer)

    Units
    (Title of Class of Securities)

    84854Q202
    (CUSIP Number)

    December 31, 2021
    (Date of Event which Requires Filing of this Statement)

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    [   ]     Rule 13d-1(b)
    [   ]     Rule 13d-1(c)
    [X]     Rule 13d-1(d)

    *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

    CUSIP No. 84854Q202
    13G
    Page 2  of 7 Pages
    1
    NAME OF REPORTING PERSON
     
    Progeny 3, Inc.
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (a)  ☐
    (b)  ☐
     
    3
    SEC USE ONLY


    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    Washington
     
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED
    BY
    EACH
    REPORTING
    PERSON
    WITH
    5
    SOLE VOTING POWER
     
    1,500,000
    6
    SHARED VOTING POWER
     
    0
    7
    SOLE DISPOSITIVE POWER
     
    1,500,000
    8
    SHARED DISPOSITIVE POWER
     
    0
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    1,500,000
    10
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES   ☐
     
     
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
    6.5%
    12
    TYPE OF REPORTING PERSON
     
    CO



    CUSIP No. 84854Q202
    13G
    Page 3 of 7 Pages
    1
    NAME OF REPORTING PERSON
     
    Jon Hemingway
    2
    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
    (a)  ☐
    (b)  ☐
     
    3
    SEC USE ONLY


    4
    CITIZENSHIP OR PLACE OF ORGANIZATION
     
    United States
     
    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED
    BY
    EACH
    REPORTING
    PERSON
    WITH
    5
    SOLE VOTING POWER
     
    1,500,000
    6
    SHARED VOTING POWER
     
    0
    7
    SOLE DISPOSITIVE POWER
     
    1,500,000
    8
    SHARED DISPOSITIVE POWER
     
    0
    9
    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     
    1,500,000
    10
    CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES  ☐
     
     
    11
    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
     
    6.5%
    12
    TYPE OF REPORTING PERSON
     
    IN



    Item 1(a)
    Name of Issuer:
       
     
    The name of the issuer is Spindletop Health Acquisition Corp (the “Company”).
       
    Item 1(b)
    Address of Issuer's Principal Executive Offices:
       
     
    The Company’s principal executive offices are located at 7000 North Mopac, Suite 315, Austin, TX 78731.
       
    Item 2(a)
    Name of Person Filing:
       
     
    This statement is filed by Progeny 3, Inc., a Washington corporation (the “Manager”), which serves as the manager of certain accounts (collectively, the “Accounts”), and Jon Hemingway (“Hemingway”), who controls the Manager.
       
     
    The foregoing persons may be referred to hereinafter as the “Reporting Person.” Any disclosures herein with respect to persons other than the Reporting Person are made on information and belief after making inquiry to the appropriate party.  The Reporting Persons have entered into a Joint Filing Agreement, a copy of which is filed with this Schedule 13G as Exhibit 1, pursuant to which they have agreed to file this Schedule 13G jointly in accordance with the provisions of Rule 13d-1(k) of the Securities Exchange Act of 1934, as amended.
       
     
    The filing of this statement should not be construed as an admission that any of the Reporting Persons is, for the purposes of Section 13 of the Act, the beneficial owner of the Units reported herein.
       
    Item 2(b)
    ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE
     
    The address of the business office of each of the Reporting Persons is 601 Union Street, Suite 3920, Seattle, WA 98101.


    Item 2(c)
    CITIZENSHIP
       
     
    The Manager is organized under the laws of the State of Washington.  Hemingway is a United States citizen.
       
    Item 2(d)
    TITLE OF CLASS OF SECURITIES
       
     
    Units
       
    Item 2(e)
    CUSIP NUMBER
       
     
    84854Q202
       
    Item 3
    IF THIS STATEMENT IS FILED PURSUANT TO Rules 13d-1(b), OR 13d-2(b) OR (c), CHECK WHETHER THE PERSON FILING IS A:
       
     
    None
       
    Item 4
    OWNERSHIP:
       
     
    The percentages used herein and in the rest of this Schedule 13G are calculated based upon the number of Units issued and outstanding as of December 31, 2021.
       
     
    The information required by Items 4(a) – (c) is set forth in Rows 5-11 of the cover page for each Reporting Person hereto and is incorporated herein by reference for each Reporting Person.
       
     
    Reporting Persons do not directly own any Common Stock.  Pursuant to investment agreements with the Accounts, the Manager maintains voting and dispositive power with respect to the securities held by the Accounts.  Hemingway controls the Manager.  Under the rules promulgated by the Securities and Exchange Commission, the Reporting Persons may be deemed to beneficially own the Common Stock.  Each Reporting Person hereby disclaims beneficial ownership of the securities covered by this statement.



    Item 5
    OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS:
       
    Not applicable.
     
       
    Item 6
    OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON:
       
     
    See Item 2. The Accounts have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Units reported herein.
       
    Item 7
    IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY OR CONTROL PERSON:
       
     
    Not applicable.
       
    Item 8
    IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP:
       
     
    Not applicable.
       
    Item 9
    NOTICE OF DISSOLUTION OF GROUP:
       
     
    Not applicable.
       
    Item 10
    CERTIFICATION:
       
     
    By signing below each Reporting Person certifies that, to the best of his or its knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under Section 240.14a-11.


    SIGNATURES

    After reasonable inquiry and to the best of his or its knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.

    DATE:  February 17, 2022

     
    Progeny 3, Inc.
       
       
     
    By:
    /s/ Jon Hemingway  
       
    Name:  Jon Hemingway
       
    Title:  CEO
       
       
     
    /s/ Jon Hemingway                                  
     
    Jon Hemingway
       
       
       
    Get the next $SHCA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SHCA

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $SHCA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Spindletop Health Acquisition Corp. Announces Key Dates in Connection with December 20, 2022 Termination Date and Liquidation

    AUSTIN, Texas, Dec. 23, 2022 /PRNewswire/ -- Spindletop Health Acquisition Corp. ("Spindletop" or the "Company") (NASDAQ:SHCA) announced that in accordance with the announced December 20, 2022 termination date set by its Board of Directors pursuant to an amendment (the "Charter Amendment") to its Amended and Restated Certificate of Incorporation (the "Charter") which was filed with the Secretary of State of the State of Delaware on December 20, 2022, the Company expects to redeem all outstanding public shares of the Company by December 27, 2022, following which the Company will be dissolved, liquidated and wound up. The Company has also requested the Nasdaq Stock Market to suspend trading of

    12/23/22 4:01:00 PM ET
    $SHCA
    Consumer Electronics/Appliances
    Industrials

    $SHCA
    SEC Filings

    View All

    SEC Form 25-NSE filed by Spindletop Health Acquisition Corp.

    25-NSE - Spindletop Health Acquisition Corp. (0001848558) (Subject)

    12/27/22 4:15:53 PM ET
    $SHCA
    Consumer Electronics/Appliances
    Industrials

    Spindletop Health Acquisition Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits

    8-K - Spindletop Health Acquisition Corp. (0001848558) (Filer)

    12/23/22 4:15:05 PM ET
    $SHCA
    Consumer Electronics/Appliances
    Industrials

    SEC Form DEF 14A filed by Spindletop Health Acquisition Corp.

    DEF 14A - Spindletop Health Acquisition Corp. (0001848558) (Filer)

    12/1/22 4:02:53 PM ET
    $SHCA
    Consumer Electronics/Appliances
    Industrials

    $SHCA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Spindletop Health Acquisition Corp. (Amendment)

    SC 13G/A - Spindletop Health Acquisition Corp. (0001848558) (Subject)

    2/9/23 10:09:12 AM ET
    $SHCA
    Consumer Electronics/Appliances
    Industrials

    SEC Form SC 13G/A filed by Spindletop Health Acquisition Corp. (Amendment)

    SC 13G/A - Spindletop Health Acquisition Corp. (0001848558) (Subject)

    1/25/23 10:41:21 AM ET
    $SHCA
    Consumer Electronics/Appliances
    Industrials

    SEC Form SC 13G filed by Spindletop Health Acquisition Corp.

    SC 13G - Spindletop Health Acquisition Corp. (0001848558) (Subject)

    2/17/22 3:32:09 PM ET
    $SHCA
    Consumer Electronics/Appliances
    Industrials